Research Site

Ciudad Autonoma Buenos Aires C1431FWO

2 studies enrolling now · 11 studies all time

What they study most

Active Cutaneous Lupus Erythematosus, Anemia, Chronic Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Kidney Disease, Diabetes Mellitus, Non-Insulin-Dependent, Endometrial Cancer, Esophagogastric Junction, Gastrointestinal Neoplasms, High Risk for Cardiovascular Event, Lupus Nephritis, Malignant Solid Tumour, Multiple Sclerosis

Studies at this site

• Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) — Recruiting now
• Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis — Recruiting now
• Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer — Running, not enrolling
• Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) — Completed
• Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease — Completed
• A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease — Completed
• Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure — Completed
• Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events — Completed
• BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis — Stopped early